Share this article

print logo

Athenex closes initial public offering of shares

Athenex Inc. on Monday announced the closing of its initial public offering of 6.9 million shares of common stock. The Buffalo-based drug developer priced its shares at $11 when trading began last Wednesday.

Athenex's shares closed at $14.52 per share on Nasdaq.

There are no comments - be the first to comment